Review





Similar Products

reproducible workflow  (Mendeley Ltd)
86
Mendeley Ltd reproducible workflow
Reproducible Workflow, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/reproducible+workflow/pmc13264291-6-16-23
Average 86 stars, based on 1 article reviews
reproducible workflow - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
workflow  (Amira Pharmaceuticals)
86
Amira Pharmaceuticals workflow
Workflow, supplied by Amira Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/amira+software+workflow/pmc13266026-271-8-4
Average 86 stars, based on 1 article reviews
workflow - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
lima workflow  (Pacific Biosciences)
86
Pacific Biosciences lima workflow
Lima Workflow, supplied by Pacific Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/0+2+lima+v2/pm42312738-49-7-9
Average 86 stars, based on 1 article reviews
lima workflow - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
circular consensus sequencing ccs workflow  (Pacific Biosciences)
86
Pacific Biosciences circular consensus sequencing ccs workflow
Circular Consensus Sequencing Ccs Workflow, supplied by Pacific Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/circular+consensus+dna+hifi+libraries+sequencing/pm42308296-279-8-17
Average 86 stars, based on 1 article reviews
circular consensus sequencing ccs workflow - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
doseedgetm pharmacy workflow manager  (Baxter Healthcare)
86
Baxter Healthcare doseedgetm pharmacy workflow manager
Doseedgetm Pharmacy Workflow Manager, supplied by Baxter Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/doseedgetm+manager+pharmacy+workflow/us12658315-165-11-17
Average 86 stars, based on 1 article reviews
doseedgetm pharmacy workflow manager - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
exosome diagnostic workflow  (Exosome Diagnostics)
86
Exosome Diagnostics exosome diagnostic workflow
Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
Exosome Diagnostic Workflow, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/diagnostic+exosome+workflow/pmc13281886-125-0-0
Average 86 stars, based on 1 article reviews
exosome diagnostic workflow - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
experimental workflows  (Novartis)
86
Novartis experimental workflows
Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
Experimental Workflows, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/experimental+workflows/pm42288212-15-9-1
Average 86 stars, based on 1 article reviews
experimental workflows - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
v2 workflow  (10X Genomics)
86
10X Genomics v2 workflow
Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
V2 Workflow, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/pm42288475-416-26-18
Average 86 stars, based on 1 article reviews
v2 workflow - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
workflow  (Sentieon Inc)
86
Sentieon Inc workflow
Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
Workflow, supplied by Sentieon Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/workflow/pm42286715-553-26-22
Average 86 stars, based on 1 article reviews
workflow - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
isolation tei workflow precipitation  (Exosome Diagnostics)
86
Exosome Diagnostics isolation tei workflow precipitation
Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
Isolation Tei Workflow Precipitation, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/workflow/isolation+precipitation+tei+workflow/pm42278575-106-18-17
Average 86 stars, based on 1 article reviews
isolation tei workflow precipitation - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Proposed workflow for exosome‑based clinical diagnostics in psoriasis. The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.

Journal: Clinical, Cosmetic and Investigational Dermatology

Article Title: Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations

doi: 10.2147/CCID.S606845

Figure Lengend Snippet: Proposed workflow for exosome‑based clinical diagnostics in psoriasis. The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.

Article Snippet: Exosome diagnostic workflow for psoriasis: 5 steps from collection to validation.

Techniques: Clinical Proteomics, Control, Biomarker Discovery